Zydus Cadila Gets Us Fda Approval To Market Sevelamer Carbonate Tablets
Zydus Cadila Has Received Final Approval From The Us Food &Amp; Drug Administration (Fda) To Market Sevelamer Carbonate Tablets In The Strength Of 800 Mg.The Drug Is A Phosphate Binder And Is Used To Control Phosphorus Levels In People With Chronic Kidney Disease Who Are On Dialysis. It Helps Prevent Hypocalcemia (Low Levels Of Calcium In The Body) Caused By Elevated Phosphorus.The Drug Will Be Manufactured At The Group&Rsquo;S Formulation Manufacturing Facility At Sez, Ahmedabad.The Group Now Has 296 Approvals And Has So Far Filed Over 390 Andas Since The Commencement Of The Filing Process In Fy 2003-04.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!